United States · Series C startup

Who invested in Truveta

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Big Data & Analytics

Valuation: $1.0B, Mar 2026

Funding summaryUpdated 15 Nov 2026

$320Mraised across 1 round since 2025, from 1 source

Latest round
Series C, $320MJan 2025
Investors
0
See who backed them

The rounds

  1. Jan 2025
    Series C$320M

    No investor was named in the report.

    Source recorded

Founders and team

From Truveta's own website: 1 founder, 13 on the team.

Terry MyersonChief Executive Officer & co-founder
  • Nick ReddyExecutive Vice President & Chief Product Officer
  • Northwell HealthExecutive Vice President & Chief General Counsel
  • Novant HealthExecutive Vice President & Chief Transformation Officer
  • Saint Luke'sVice President & Chief Data Officer
  • Tenet HealthSenior Vice President, Chief Clinical Operations Officer
  • Trinity HealthExecutive Vice President & Chief Operating Officer
  • UnityPoint HealthSenior Vice President & Chief Information Officer
  • Bon Secours Mercy HealthVice President of Digital Ventures
  • Providence HealthPresident & CEO
  • Advocate HealthChief Information Officer
  • Deb NielsenChief People Officer
  • Memorial Hermann Health SystemChief Digital Officer
  • Simonne LawrenceGeneral Counsel

Quick answers about Truveta

How much has Truveta raised?

Truveta has raised $320M across 1 round since 2025.

When did Truveta last raise?

Truveta's most recent round was a Series C of $320M in Jan 2025.

What was Truveta's biggest round?

Its most recent round, $320M in Jan 2025, is also its largest on record.

What stage is Truveta at?

Truveta's latest named round is a Series C, in Jan 2025.

Where is Truveta based?

Truveta is based in the United States.

Companies like Truveta

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.